To determine whether administration of G-CSF induces phenotypic or functional changes in T cells, we examined peripheral blood T cells from normal individuals receiving G-CSF for activation antigen and adhesion molecule expression before and after G-CSF administration. G-CSF (10 g/kg/day) was administered subcutaneously to 14 normal individuals for 3-5 days and their PBMC were serially analyzed with monoclonal Ab (mAb) directed to HLA-DR, CD45RO, CD45RA, CD25, CD122, CD95, CD11a, CD49d, CD44 and CD62L (Lselectin) coupled with anti-CD3 mAb. Among T cells positive for these antigens, only the proportion of T cells expressing L-selectin significantly decreased from 68% to 37% after 3-day G-CSF administration. When peripheral blood CD3 + T cells obtained before and after G-CSF administration were sorted into two populations depending on the expression of L-selectin and tested for their proliferative response to allogeneic B cells, the reactivity of L-selectin − cells to alloantigen stimulation was consistently lower than that of L-selectin + cells regardless of the exposure to G-CSF. The decrease in the relative number of L-selectin + cells induced by G-CSF administration may contribute to the unexpectedly low incidence of severe acute GVHD after allogeneic PBSC transplantation. Keywords: L-selectin; G-CSF; allogeneic PBSCT Allogeneic PBSC transplantation (allo-PBSCT) is being increasingly used for treatment of hematologic malignancies.
cell populations after G-CSF administration; recent studies have shown that after G-CSF administration there is an increase in the Th2/Th1 ratio in mice 7 and an increase in CD4 − CD8 − T cells in both mice and humans. 8 However, there are no reports of changes in the T cell phenotype associated with G-CSF administration, although an increase in the serum concentration of soluble interleukin-2 receptor suggesting G-CSF-induced activation of T cells has been shown. 9 In the present study, we focused on changes in the expression of activation antigens and adhesion molecules on T cells after G-CSF administration to normal individuals. We found that among a series of molecules associated with T cell activation and adhesion, only the proportion of L-selectin + T cells decreased after G-CSF administration. We also analyzed the functional differences between Lselectin + and L-selectin − T cells before and after G-CSF administration.
Materials and methods

Cell preparation
G-CSF (Filgrastim, Kirin Brewery Co, Tokyo, Japan), 10 g/kg/day was administered to 14 normal individuals by subcutaneous injection for 3-5 days after informed consent. Eleven of the 14 were donors for allo-PBSCT and the other three were volunteers. Peripheral blood (PB) samples were taken for lymphocyte analysis just before and every day after G-CSF administration. PBMC were isolated from heparinized blood using Ficoll-Hypaque (Nycomed Pharma, Oslo, Norway) density gradient centrifugation. In some experiments, PBMC were separated into E-rosetting and non-rosetting cells by rosette formation with 2-aminoethilisothiouronium bromide (AET, Sigma Chemical, St Louis, MO, USA)-treated sheep red blood cells, followed by Ficoll-Hypaque gradient centrifugation as described. 10 
Phenotypic analysis of T cells
FITC-or PE-conjugated mAb recognizing the following antigens were used for the analysis of the surface phenotypes of lymphocytes: CD3, CD4, CD8, HLA-DR, CD45RO, CD45RA, CD49d (VLA-4), CD44 (PharMingen, San Diego, CA, USA), CD11a (LFA-1) (Sanbio Co, Uden, The Netherlands), CD62L (L-selectin) (Immunotech, Hialeah, FL, USA), CD25 (IL2-␣) (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA), CD122 (IL2-␤) (Nichirei Co, Tokyo, Japan), CD95 (Fas) (MBL, Nagoya, Japan). mAb recognizing adhesion molecules such as CD49d, CD44, CD11a and L-selectin were used for study since previous reports demonstrated that G-CSF could modulate the expression of several adhesion molecules on blood cells. 11, 12 The expression of HLA-DR, CD25, CD122 and CD95 were examined since these antigens are sensitive markers for T cell activation. PBMC suspended in RPMI 1640 medium (Gibco, Grand Island, NY, USA) were aliquoted into 15-20 tubes. To each tube mAb was added and incubated for 30 min at 4°C and washed twice with PBS (Nissui Seiyaku Co, Tokyo, Japan). Flow cytometric analysis was performed using a FACScan flow cytometer (Becton Dickinson).
Culture of PBMC
PBMC obtained from three donors at day 4 after G-CSF administration were suspended in RPMI 1640 containing 10% FCS (Gibco) at a concentration of 1 × 10 6 /ml and cultured in a CO 2 incubator for 50 h. PBMC obtained before G-CSF administration were cultured in the same medium with or without G-CSF for 2-4 days.
Establishment of EBV-transformed lymphoblastoid cell lines (LCLs)
PBMC from three donor-recipient pairs and from a normal individual were depleted of T cells using the rosette formation method. Then, 2-3 × 10 6 non-T cells were incubated in 10% FCS-RPMI 1640 containing 10% culture medium of an EBV-producing cell line, B95-8, at 37°C for 2 h. EBV-infected cells were cultured for 3 weeks until transformed LCL cells grew. LCL cells were maintained by changing the medium every 4-5 days.
Cell sorting
Isolation of CD62L
+ T cells and CD62L − T cells from Erosetting cells was performed using an EPICS-C flow cytometer (Coulter Electronic, Hialeah, FL, USA) as described. 13 
MLR
A total of 2.5 × 10 5 sorted T cells were suspended in RPMI 1640 medium supplemented with 7.5% pooled human AB serum, 100 U/ml penicillin, and 100 mg/ml streptomycin and cultured in 96-well U-bottomed plates (Iwaki Grass Co, Tokyo, Japan) with an equal number of 45 Gy irradiated autologous LCL or allogeneic LCL cells, and 1 × 10 4 irradiated E-rosetting cells. After a 6-day incubation, 20 Ci of 3 H-thymidine (TdR; Ci/mm, DuPont NEN Products, Boston, MA, USA) was added to each well. Cultured cells were harvested after 6 h, and 3 H-TdR incorporation was measured using a plate (UNI PLATE; Packard Instrument Co, Tokyo, Japan) and a liquid scintillation counter. To eliminate the influence of reactivity to EB virus antigens and variation in reactivity caused by artifacts, the alloreactivity of T cells from each individual was assessed by the following equation: + cells in the peripheral blood after G-CSF administration. PBMC were collected from normal individuals before and after G-CSF administration and expression of L-selectin on T cells was examined using mAb to CD62L coupled with anti-CD3 mAb. A representative series of histograms is shown. Table 1 summarizes the results of phenotypic analysis of T cells obtained from 14 normal individuals before and after G-CSF administration. CD3
Results
Changes in the phenotype of T cells induced by G-CSF administration
+ cells in the PB increased 1.4 ± 0.3 (mean ± standard deviation)-fold on day 4 after G-CSF treatment. There were no significant differences in levels of HLA-DR, CD45RO, CD45RA, CD25, CD122, CD95, CD11a, CD44 or CD49d between CD3 + T cells obtained before and 4 days after G-CSF administration. However, the proportion of T cells expressing L-selectin significantly decreased after treatment from 68 ± 15% to 37 ± 27% (P = 0.0068). CD3
+ cells expressing L-selectin and those not expressing the adhesion molecule were designated as L-selectin + T cells and L-selectin − T cells, respectively (Figure 1 ). L-selectin + T cells in the PB decreased to 0.7 ± 0.2 times the pretreatment value after G-CSF administration. The proportion of L-selectin + T cells began to decrease on day 2 and reached the lowest level on day 4 after the initiation of G-CSF injections (Figure 2) . It returned to pre-G-CSF levels within 1 week following cessation of G-CSF administration (data not shown). The decrease in the proportion of L-selectin + cells occurred equally in CD4
+ cells and CD8 + cells (Figure 3 ). When the expression of L-selectin on bone marrow T cells from two normal individuals was examined, the proportion of Lselectin + cells (72 ± 14%) to total T cells and their fluorescence intensity were similar to T cells in the PB (data not shown). To determine whether L-selectin − T cells that emerged in the PB after G-CSF administration are capable of expressing L-selectin, PBMC obtained 4 days after G-CSF administration were incubated in 10% FCS-RPMI 1640 at 37°C in a CO 2 incubator and the expression of L-selectin was serially examined. As shown in Figure 4 , the proportion of L-selectin + T cells gradually increased, exceeding normal levels 10 h after culture.
Effect of G-CSF on the expression of L-selectin by T cells in vitro
PBMC were suspended in 10% FCS-RPMI 1640 containing G-CSF at a concentration of 10 ng/ml or 100 ng/ml and incubated in a CO 2 incubator. The proportion of the Lselectin + T cells to total T cells did not decrease over time, indicating that G-CSF does not directly downregulate the expression of L-selectin by T cells ( Table 2) .
Response of L-selectin + and L-selectin − T cells to alloantigen stimulation
PB CD3
+ cells from three normal individuals obtained before G-CSF administration and 4 days after G-CSF administration were separated into L-selectin + and Lselectin − cells using a cell sorter ( Figure 5 ), and the proliferative responses of each cell population to autologous and allogeneic LCL cells were examined. Figure 6 shows the response of each donor's cell populations to allogeneic and autologous LCL cells. The uptake when stimulated with autologous LCL cells was consistently greater than uptake by L-selectin − T cells regardless of G-CSF exposure. When the proliferative response of each T cell population against LCL cells derived from an HLA-identical sibling was examined, Lselectin + T cells exhibited a higher response than L-selectin − T cells did (Table 3) .
Discussion
The present analysis of the adhesion molecules and activation antigens on T cells in the PB has revealed that the proportion of L-selectin + T cells to total T cells significantly 14 The decrease in Lselectin + T cells might be caused by shedding of L-selectin after G-CSF treatment. It has been previously demonstrated that G-CSF induces shedding of L-selectin from neutrophils and monocytes, 15 although shedding from T cells associated with G-CSF administration has not been demonstrated. Lselectin is shed upon T cell activation, 16, 17 and although T cells do not have G-CSF receptors, 18 administration of G-CSF might stimulate monocytes to produce monokines and thereby activate T cells in vivo. 19 Recent reports showing increased expression of several activation antigens such as CD69 on T cells exposed to G-CSF in vivo 20 support this hypothesis. Demonstration of increased serum levels of Lselectin may be useful in determining whether circulating T cells shed L-selectin after G-CSF administration. However, since serum levels of L-selectin are influenced by shedding of the molecule from neutrophils and monocytes, we were not able to prove shedding of L-selectin from T cells using this method.
It is possible that the preferential mobilization of Lselectin − T cells into the circulation by administration of G-CSF may contribute to an increase in their number. Although a mechanism for CD3 + cell mobilization after G-CSF administration has not been found, studies have documented the importance of adhesion molecules in the mobilization of CD34 + cells. 11,12 L-selectin − T cells may be more likely to migrate in response to G-CSF administration than Table 3 Proliferative response to HLA-identical allogeneic LCL cells 
L-selectin
+ T cells, leading to a preferential increase in Lselectin − T cells in the PB. Under physiologic conditions, 68 ± 15% of T cells in the PB expressed L-selectin. Adhesion molecules play a key role in the initial adhesion of T cells to the luminal surface of high endothelial venules, leading to the recirculation of T cells through peripheral lymph nodes. [21] [22] [23] T cells in the PB need to return to the lymph node for efficient sensitization by foreign antigens presented by antigen presenting cells. 24 In L-selectin-deficient mice, T cells in the PB cannot return to the lymphoid system and remain in the circulation and the spleen. 25, 26 Thus, it is possible that Lselectin − T cells in the PB graft may be less efficiently sensitized by alloantigen after infusion into a recipient than L-selectin + T cells, due to their inability to migrate into the lymphoid system, preventing acute GVHD. Infusing radiolabelled T cell subpopulations and comparing the time for disappearance from the circulation between L-selectin + T cells and L-selectin − T cells may be useful for testing this hypothesis.
Although the role of L-selectin in the migration of T cells has been extensively studied, 27 little is known about the functional differences between L-selectin + T cells and Lselectin − T cells. Most naive CD4 + T cells are L-selectin + , and memory CD4 + T cells contain both L-selectin − and Lselectin + populations. 28 A recent study has demonstrated that L-selectin − CD4 + T cells in the PB of normal adults produce more interferon-␥ and less interleukin-4 than Lselectin + T cells. 29 In addition, T cells capable of attacking tumor cells and allogeneic skin grafts are L-selectin − .
30,31
Accordingly, we expected that L-selectin − T cells would exhibit a larger response to alloantigen than L-selectin + T cells. In three normal individuals studied, however, the response of L-selectin − T cells to allogeneic LCL cells was consistently lower than that of L-selectin + T cells. Administration of G-CSF did not affect the proliferative response of the isolated T cell subsets. Recently, Konno et al 32 demonstrated that L-selectin on T cells played a major role in initiation of B cell activation. Our results suggest that Lselectin on T cells may also have a role in the recognition of alloantigens presented by B cells. Since L-selectin − T cells that appeared after G-CSF administration recovered a high level of expression of L-selectin after 10 h culture, the cultured L-selectin − T cells may restore high response to allogeneic LCL cells. We are currently testing these possibilities by studying a large sample of individuals.
The decrease in the number of L-selectin + T cells after G-CSF administration appears to have important implications for the clinical outcome of allo-PBSCT. In this study, the majority of T cells collected from a healthy donor receiving G-CSF were L-selectin − . When the PBSC graft from a normal individual collected by pheresis of 15 l of PB after G-CSF administration was examined, the number of L-selectin + cells was approximately 1.9 × 10 8 /kg, only three-fold higher than that in the bone marrow graft (data not shown). Thus, infusion of peripheral blood buffy coats collected after G-CSF administration may be less likely to produce alloantigen reactions than those not exposed to G-CSF in vivo. This may account for the unexpectedly low incidence of acute GVHD after allo-PBSCT.
